Literature DB >> 31097897

The role of the immune system in brain metastasis.

Adam T Leibold1, Gina N Monaco1, Mahua Dey1.   

Abstract

Metastatic brain tumors are the most common brain tumors in adults. With numerous successful advancements in systemic treatment of most common cancer types, brain metastasis is becoming increasingly important in the overall prognosis of cancer patients. Brain metastasis of peripheral tumor is the result of complex interplay of primary tumor, immune system and central nervous system microenvironment. Once formed, brain metastases hide behind the blood brain barrier and become inaccessible to chemotherapies that are otherwise successful in targeting systemic cancer. The approval of immune checkpoint inhibitors for several common cancers such as advanced melanoma and lung cancers brings with it the opportunity and obligation to further understand the mechanisms of immunosuppression by tumors that spread to the brain as well as the interaction between the brain environment and tumor microenvironment. In this review paper we define the central role of the immune system in the development of brain metastases. We performed a comprehensive review of the literature to outline the molecular mechanisms of immunosuppression used by tumors and how the immune system interacts with the central nervous system to facilitate brain metastasis. In particular we discuss the tumor-type-specific mechanisms of metastasis of cancers that preferentially metastasize to the brain as well as the therapies that effectively modulate the immune response, such as immune checkpoint inhibitors and vaccines.

Entities:  

Keywords:  brain metastasis; immune system; immunotherapy; metastatic lung cancer; metastatic melanoma

Year:  2019        PMID: 31097897      PMCID: PMC6513348     

Source DB:  PubMed          Journal:  Curr Neurobiol        ISSN: 0975-9042


  133 in total

Review 1.  Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions.

Authors:  Damya Laoui; Kiavash Movahedi; Eva Van Overmeire; Jan Van den Bossche; Elio Schouppe; Camille Mommer; Alexandros Nikolaou; Yannick Morias; Patrick De Baetselier; Jo A Van Ginderachter
Journal:  Int J Dev Biol       Date:  2011       Impact factor: 2.203

2.  Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.

Authors:  Beatriz M Carreno; Vincent Magrini; Michelle Becker-Hapak; Saghar Kaabinejadian; Jasreet Hundal; Allegra A Petti; Amy Ly; Wen-Rong Lie; William H Hildebrand; Elaine R Mardis; Gerald P Linette
Journal:  Science       Date:  2015-04-02       Impact factor: 47.728

3.  An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer.

Authors:  Encouse B Golden; Sandra Demaria; Peter B Schiff; Abraham Chachoua; Silvia C Formenti
Journal:  Cancer Immunol Res       Date:  2013-12       Impact factor: 11.151

Review 4.  The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer.

Authors:  Solange Peters; Christin Bexelius; Veronica Munk; Natasha Leighl
Journal:  Cancer Treat Rev       Date:  2016-03-15       Impact factor: 12.111

5.  Estimating the additive benefit of surgical excision to stereotactic radiosurgery in the management of metastatic brain disease.

Authors:  Matthew R Quigley; Nicholas Bello; Diana Jho; Russell Fuhrer; Stephen Karlovits; Farrel J Buchinsky
Journal:  Neurosurgery       Date:  2015-06       Impact factor: 4.654

Review 6.  Dendritic cell vaccines for brain tumors.

Authors:  Won Kim; Linda M Liau
Journal:  Neurosurg Clin N Am       Date:  2010-01       Impact factor: 2.509

7.  Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner.

Authors:  Rikke B Holmgaard; Dmitriy Zamarin; Yanyun Li; Billel Gasmi; David H Munn; James P Allison; Taha Merghoub; Jedd D Wolchok
Journal:  Cell Rep       Date:  2015-09-24       Impact factor: 9.423

Review 8.  IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance.

Authors:  David H Munn; Andrew L Mellor
Journal:  Trends Immunol       Date:  2016-01-31       Impact factor: 16.687

9.  Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.

Authors:  Daniel N Cagney; Allison M Martin; Paul J Catalano; Amanda J Redig; Nancy U Lin; Eudocia Q Lee; Patrick Y Wen; Ian F Dunn; Wenya Linda Bi; Stephanie E Weiss; Daphne A Haas-Kogan; Brian M Alexander; Ayal A Aizer
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 12.300

Review 10.  Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions.

Authors:  Yifan Wang; Weiye Deng; Nan Li; Shinya Neri; Amrish Sharma; Wen Jiang; Steven H Lin
Journal:  Front Pharmacol       Date:  2018-03-05       Impact factor: 5.810

View more
  13 in total

Review 1.  Salting the Soil: Targeting the Microenvironment of Brain Metastases.

Authors:  Ethan S Srinivasan; Aaron C Tan; Carey K Anders; Ann Marie Pendergast; Dorothy A Sipkins; David M Ashley; Peter E Fecci; Mustafa Khasraw
Journal:  Mol Cancer Ther       Date:  2021-01-05       Impact factor: 6.261

Review 2.  Emerging principles of brain immunology and immune checkpoint blockade in brain metastases.

Authors:  Jawad Fares; Ilya Ulasov; Peter Timashev; Maciej S Lesniak
Journal:  Brain       Date:  2021-05-07       Impact factor: 13.501

3.  The Analysis of Human Serum N-Glycosylation in Patients with Primary and Metastatic Brain Tumors.

Authors:  Csaba Váradi; Viktória Hajdu; Flóra Farkas; Ibolya Gilányi; Csaba Oláh; Béla Viskolcz
Journal:  Life (Basel)       Date:  2021-01-06

Review 4.  Modulation of the Complement System by Neoplastic Disease of the Central Nervous System.

Authors:  Steven K Yarmoska; Ali M Alawieh; Stephen Tomlinson; Kimberly B Hoang
Journal:  Front Immunol       Date:  2021-10-04       Impact factor: 7.561

Review 5.  Multidisciplinary Management of Brain Metastases from Non-Small Cell Lung Cancer in the Era of Immunotherapy.

Authors:  Lisa Sudmeier; Sibo Tian; Kristin A Higgins
Journal:  Curr Treat Options Oncol       Date:  2021-07-02

Review 6.  Next-generation immunotherapies for brain metastatic cancers.

Authors:  María López Vázquez; Wanlu Du; Nobuhiko Kanaya; Yohei Kitamura; Khalid Shah
Journal:  Trends Cancer       Date:  2021-03-12

Review 7.  Suppressing immunotherapy by organ-specific tumor microenvironments: what is in the brain?

Authors:  Chenyu Zhang; Dihua Yu
Journal:  Cell Biosci       Date:  2019-10-07       Impact factor: 7.133

Review 8.  Antibodies for the Treatment of Brain Metastases, a Dream or a Reality?

Authors:  Marco Cavaco; Diana Gaspar; Miguel Arb Castanho; Vera Neves
Journal:  Pharmaceutics       Date:  2020-01-13       Impact factor: 6.321

Review 9.  Sex steroid hormone function in the brain niche: Implications for brain metastatic colonization and progression.

Authors:  María J Contreras-Zárate; Diana M Cittelly
Journal:  Cancer Rep (Hoboken)       Date:  2020-03-03

10.  Association between PD-L1 expression and initial brain metastasis in patients with non-small cell lung cancer and its clinical implications.

Authors:  Kyoungmin Lee; Yoon J Choi; Jung S Kim; Dae S Kim; Sung Y Lee; Bong K Shin; Eun J Kang
Journal:  Thorac Cancer       Date:  2021-06-13       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.